CRP-positive patients had a significantly poorer prognosis than patients whose levels were below the cut-off value (log-rank test, p<0.01; cancer-specific survival rate: CRP-positive, 89.5%; CRP-negative, 66.6%). This evidence concerns the gene CRP and cancer.